Glucose Health, Inc. income statement GLUC

Annual Quarterly

Net income was $18,769.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2017	Q3 FY2017 Sep 30, 2017	Q2 FY2017 Jun 30, 2017	Q1 FY2017 Mar 31, 2017	Q4 FY2016 Dec 31, 2016	Q3 FY2016 Sep 30, 2016	Q2 FY2016 Jun 30, 2016	Q1 FY2016 Mar 31, 2016	Q4 FY2015 Dec 31, 2015
Cost of revenue	0 -89.1%	0 -83.3%	0 -99.9%	0 +24296.7%	0 +834.0%	0 +142.8%	0 +80624.7%	0 -94.0%	0 +116.2%
Gross profit	0 +205.9%	0 +976.3%	0 +58.2%	0 +688.3%	0 +601.8%	-0 -2599.0%	0 +9968.4%	0 +140.0%	0 +100.5%
Selling, general and administrative	0 -74.6%	0 -87.1%	0 +31.0%	0 +328.2%	0 -91.4%	0 +56.9%	0 -36.6%	0 -13.8%	0 +3850.8%
Operating income	-0 +57.7%	0 +108.3%	0 +166.5%	-0 -130.7%	-0 -66.6%	-0 -62.6%	0 +114.2%	-0 +81.0%	-0 +95.9%
Other income (expense)	-0 +79.5%	0 +113.4%	0 +135.5%	-0 +95.9%	-0 -211.2%	-0 -597.8%	-0 -1122.2%	-0 +69.3%	-0 +42.1%
Pretax income	-0 +74.5%	0 +111.7%	0 +156.4%	-0 +0.9%	-0 -165.1%	-0 -226.5%	-0 -74.7%	-0 +75.6%	-0 +88.8%
Net income	-0 +74.5%	0 +111.7%	0 +156.4%	-0 +0.9%	-0 -165.1%	-0 -226.5%	-0 -74.7%	-0 +75.6%	-0 +88.8%
Basic EPS	-0.02 +82.3%	0.00 +100.0%	0.01 +133.3%	-0.01 +0.0%	-0.04 -79.4%	-0.06 -200.0%	-0.03 +0.0%	-0.01 +87.5%	-0.02 +93.7%
Weighted average shares, basic	4 +44.0%	4 +44.2%	4 +43.7%	3 +33.5%	3 +47.8%	3 +34.9%	3 +33.7%	3 +60.3%	2 +79.9%
Other measures
Interest coverage	-0.29x	0.81x	3.15x	-40.68x	-0.25x	-0.53x	0.06x	-0.72x	-0.70x

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: GLUC (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Bentonville, AR
SEC filer status: Smaller reporting company
SEC CIK: 1420108
Former names: Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.